SG Americas Securities
CRBU icon

SG Americas Securities’s Caribou Biosciences CRBU Stock Holding History

SG Americas Securities’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,406
Closed -$35K – 3053
2025
Q1 		$35K Buy
38,406
+8,063
+27% +$10.5K ﹤0.01% 3311
2024
Q4 		$48K Buy
30,343
+1,623
+6% +$3.26K ﹤0.01% 2912
2024
Q3 		$56K Buy
28,720
+5,309
+23% +$10.9K ﹤0.01% 3221
2024
Q2 		$38K Sell
23,411
-3,224
-12% -$10.3K ﹤0.01% 2719
2024
Q1 		$137K Sell
26,635
-12,942
-33% -$79.8K ﹤0.01% 2283
2023
Q4 		$227K Buy
+39,577
New +$196K ﹤0.01% 2043
2023
Q2 		– Sell
-22,295
Closed -$118K – 2451
2023
Q1 		$118K Sell
22,295
-3,074
-12% -$19.1K ﹤0.01% 2807
2022
Q4 		$159K Buy
25,369
+1,929
+8% +$17.2K ﹤0.01% 2377
2022
Q3 		$247K Buy
23,440
+8,093
+53% +$75.4K ﹤0.01% 2145
2022
Q2 		$83K Buy
+15,347
New +$117K ﹤0.01% 3181
2021
Q4 		– Sell
-8,640
Closed -$206K – 3445
2021
Q3 		$206K Buy
+8,640
New +$211K ﹤0.01% 3216

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities's CRBU Position: Q2 2025 in Review

SG Americas Securities sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 38,406 shares — an estimated $35K sold.

SG Americas Securities first reported a position in CRBU in Q3 2021 and held it in 11 quarters. The position peaked at $247K in Q3 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • SG Americas Securities reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 38,406 Caribou Biosciences shares in Q2 2025, an estimated $35K.
  • SG Americas Securities first reported a position in Caribou Biosciences in Q3 2021 and held it in 11 quarters.
  • SG Americas Securities's Caribou Biosciences position peaked at $247K in Q3 2022.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.